NeuroVive begins phase Ia/b clinical study of KL1333 to treat genetic mitochondrial disorders | Pharmabiz wishes all its readers and advertisers A Happy Holi. The site will not be updated on March 21, 2019.
       
  Editorial
 THE NCISM BILL   
 Wednesday, March 20, 2019 
 The Union government will soon come out with the National Commission for Indian Systems of Medicine (NCISM) Bill. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]NeuroVive begins phase Ia/b clinical study of KL1333 to treat genetic mitochondrial disorders
17:15  [IST]Medical experts see head injuries need to be attended within golden hour period
17:00  [IST]C2 PHARMA buys Digoxin API portfolio from Nobilus Ent
16:20  [IST]Apollo signs MoU with ApnaComplex to establish 75 housing society clinics by 2022
16:10  [IST]Multi-city ‘Race for 7’ run to raise awareness for rare disease patients; NGO stresses for orphan drug policy
16:00  [IST]Mylan recalls two lots of levoleucovorin injection from US market due to presence of particulate matter
more news >>
TOP NEWS
08:00  [IST]Ayush sector records robust growth; number of institutionally qualified practitioners, facilities rising: Says govt data
08:00  [IST]Pharma MSMEs seek financial support & phase wise implementation of proposed revision of Schedule M
08:00  [IST]Pharmacists are in doldrums as Central and state govts neglect their roles everywhere: Expert
08:00  [IST]Delhi, Mumbai HCs strike down Ministry of Ayush notification on banning ads
08:00  [IST]Abbott launches a:care digital service in India to bridge communication between patients, doctors
08:00  [IST]NPPA reviews data from coronary stent makers, importers to revise ceiling price in accordance with WPI; current rates valid till March end
more news >>
YESTERDAY'S NEWS
18:00  [IST]Boston Scientific presents positive safety, efficacy data for Luminize RF Balloon Catheter at EHRA 2019 congress
17:00  [IST]OliX Pharma, Théa collaborates to develop RNAi therapies for AMD treatment
16:00  [IST]AstraZeneca’s saracatinib to treat idiopathic pulmonary fibrosis receives US FDA orphan drug designation
15:00  [IST]Study suggests tiny electrical brain waves may be a hallmark of successful memory retrieval
14:40  [IST]Schott Kaisha to expand further in Gujarat and North India
14:00  [IST]European Commission approves Praluent to reduce risk of CV events in patients with established cardiovascular disease
more news >>
INTERVIEW  
Cyber security key in pharma and healthcare to ensure protection of information
Jaykishan Nirmal, senior vice president 113648interview
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Chemspec_india_2019
PharmaLytica150x60_2019
cphi_china_150-60-2019
CPhI-Japan-150x60px_2019
CPhI-SEA150x60px-PanelAd_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |